Skip to main content
. 2022 Mar 28;40(19):2781–2789. doi: 10.1016/j.vaccine.2022.03.030

Table 4.

Model predicted benefit-risk outcomes of Scenarios 1–3 for the 16–17-year-old subgroups.

Scenario Benefits
Risks
Prevented COVID-19 Cases Prevented COVID-19 Hospitalizations Prevented COVID-19 ICUs Prevented COVID-19 Deaths Excess Myocarditis Cases Excess Myocarditis Hospitalizations Excess Myocarditis Deaths
Males & Females
Scenario 1 19,425 241 59 2 116 116 0
Scenario 2 151,080 855 210 6 116 116 0
Scenario 3 15,108 214 52 1 116 116 0



Males only
Scenario 1 17,456 142 47 1 196 196 0
Scenario 2 135,771 506 166 4 196 196 0
Scenario 3 13,577 127 41 1 196 196 0



Females only
Scenario 1 21,657 350 68 2 36 36 0
Scenario 2 168,443 1245 243 9 36 36 0
Scenario 3 16,844 311 61 2 36 36 0